|Podcasts|May 1, 2023
Baxter BioPharma Solutions latest $100M investment in Baxter’s Halle/Westfalen, Germany facility
Author(s)Baxter
In this podcast, Kayleigh Hearse, Sr Mgr. Technical Projects, Capacity Expansion Pharma Production shares details of Baxter BioPharma Solution’s approximately $100 million expansion of its sterile fill/finish manufacturing facility located in Halle/Westfalen, Germany. Kayleigh explains many of the key attributes of the new building, key learnings and major considerations that took place throughout the planning phase.
Related Content
Trending on Pharmaceutical Technology
1
Roche Gets Priority Review for Enspryng; Announces Sequencing Platform
2
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
3
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
4
Regulatory Developments Impacting Biologics
5